Celularity (CELU) Gross Profit (2020 - 2025)
Celularity (CELU) posted quarterly Gross Profit of -$3.3 million for Q4 2025, up 50.86% year-over-year from -$2.2 million in Q4 2024, and down 336.96% quarter-over-quarter from $1.4 million in Q3 2025.
Celularity (CELU) Gross Profit (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Gross Profit for 6 consecutive years, with -$3.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Gross Profit rose 50.86% year-over-year to -$3.3 million; the TTM figure through Dec 2025 stood at $6.5 million (down 70.28% YoY), while the FY2025 annual figure was $6.5 million, down 83.49% from the prior year.
- Gross Profit retreated to -$3.3 million in Q4 2025 per CELU's latest filing, from $1.4 million in the prior quarter.
- Across five years, Gross Profit topped out at $13.0 million in Q1 2024 and bottomed at -$6.7 million in Q4 2024.
- Historically, Gross Profit has averaged $2.9 million across 5 years, with a median of $2.4 million in 2022.
- On a YoY basis, Gross Profit climbed as much as 2841.85% in 2024 and fell as far as 365.88% in 2024.
- Celularity's Gross Profit stood at $4.6 million in 2021, then slumped by 242.13% to -$6.5 million in 2022, then jumped by 138.3% to $2.5 million in 2023, then slumped by 365.88% to -$6.7 million in 2024, then jumped by 50.86% to -$3.3 million in 2025.
- Business Quant data shows CELU's Gross Profit at -$3.3 million in Q4 2025, $1.4 million in Q3 2025, and $494000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.27 Mn |
| Dec 31, 2025 | -3.27 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 494,000.00 |
| Jun 30, 2025 | 494,000.00 |
| Mar 31, 2025 | 7.87 Mn |
| Mar 31, 2025 | 7.87 Mn |
| Dec 31, 2024 | -6.66 Mn |
| Dec 31, 2024 | -6.66 Mn |
| Sep 30, 2024 | 5.41 Mn |
| Sep 30, 2024 | 5.41 Mn |
| Jun 30, 2024 | 9.99 Mn |
| Jun 30, 2024 | 9.99 Mn |
| Mar 31, 2024 | 13.04 Mn |
| Mar 31, 2024 | 13.04 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | 184,000.00 |
| Sep 30, 2023 | 184,000.00 |